Life Science News

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces that it has closed the second tranche of its previously announced non-brokered private placement offering (the "Offering") and has issued 2,770,000 units (the "Units") at $0.20 per Unit for gross proceeds of C$554,000. Combined with the first tranche of the Offering, the Company has sold 7,920,000 Units of the Company for aggregate gross proceeds of C$1,584,000. The Units are comprised of (i) one (1) common share in the capital of the Company ("Common Shares"); and (ii) one-half (12) of a transferable common share purchase warrant (each whole warrant, a "Warrant" and collectively, the "Warrants"). Each Warrant entitles the holder thereof to acquire one (1) additional Common Share (each, a "Warrant Share") in the capital of the Company at a price of $0.30 per Warrant Share until July 18, 2023. The net proceeds of the Offering will be used by the Company for ongoing working capital and corporate development.

In connection with closing the second tranche of the Offering, the Company paid C$32,640 and issued 163,200 Warrants, exercisable at a price of $0.30 per Warrant Share until July 18, 2023 to an arms-length party who assisted in introducing subscribers to the Offering. All securities issued in connection with the Offering are subject to a statutory hold period until November 19, 2022 in accordance with applicable securities laws.

Investor Relations Engagement

The Company also announces that its board of directors has approved a change in the duties of an existing consultant to the Company, Spiro Kletas, to include advising the Company on shareholder communications and financing strategy. Mr. Kletas is presently compensated at a rate of $6,000 per month, and will continue at this rate. In consideration for his additional duties, Mr. Kletas has also been granted 150,000 incentive stock options, vesting over a twelve-month period and exercisable at a price of $0.40 until July 5, 2025.

About Bloom Health Partners Inc.

Bloom Health Partners Inc. is a global platform for healthcare security, diagnostic testing and occupational health-tech. Our mission is to ensure that "unstoppable is possible" for businesses and their employees through innovative, customized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.

For more information on the Company, please email investors@bloomhealthpartners.com

On behalf of the board of directors,

Bloom Health Partners Inc.
Andrew Morton, Chief Executive Officer

Forward-Looking Statements

This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company's forward-looking statements include the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company's filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/131225

News Provided by Newsfile via QuoteMedia

BLMH:CNX
Bloom Health Partners

Bloom Health Partners


Keep reading...Show less
Bloom Health Partners Announces Closing of First Tranche of Private Placement

Bloom Health Partners Announces Closing of First Tranche of Private Placement

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces that it has closed an initial tranche of its non-brokered private placement offering (the "Offering") and has issued 5,150,000 units (the "Units") at $0.20 per Unit for gross proceeds of $1,030,000. The Units are comprised of (i) one (1) common share in the capital of the Company ("Common Shares"); and (ii) one-half (12) of a transferable common share purchase warrant (each whole warrant, a "Warrant" and collectively, the "Warrants"). Each Warrant entitles the holder thereof to acquire one (1) additional Common Share (each, a "Warrant Share") in the capital of the Company at a price of $0.30 per Warrant Share until July 6, 2023. The net proceeds of the Offering will be used by the Company for ongoing working capital and corporate development.

The initial tranche of the Offering was led by Ascenta Finance Corp., an exempt market dealer based in Vancouver, British Columbia. In connection with closing the initial tranche of the Offering, the Company paid $39,900, issued 3,000 Warrants, exercisable at a price of $0.20 per Warrant Share until July 6, 2023, and 196,500 compensation options (each, an "Option") to certain arms-length parties who assisted in introducing subscribers to the Offering. Each Option is exercisable to acquire a Unit under the same terms as the Offering until July 6, 2023. All securities issued in connection with the Offering are subject to a statutory hold period until November 7, 2022 in accordance with applicable securities laws.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Launches $2 Million Non-Brokered Private Placement

Bloom Health Partners Launches $2 Million Non-Brokered Private Placement

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces that it has engaged Ascenta Finance Corp. ("Ascenta") to lead a non-brokered private placement offering (the "Offering") of units (the "Units") at $0.20 per Unit for gross proceeds of up to $2,000,000. The Units are comprised of (i) one (1) common share in the capital of the Company ("Common Shares"); and (ii) one-half (12) transferable common share purchase warrant (each whole warrant, a "Warrant" and collectively, the "Warrants"). Each whole Warrant shall entitle the holder thereof to acquire one (1) additional Common Share (each, a "Warrant Share") in the capital of the Company at a price of $0.30 per Warrant Share until the date that is twelve (12) months from the Closing Date, as defined herein. The net proceeds of the Offering will be used by the Company for ongoing working capital and corporate development.

The Common Shares and the Warrants will be subject to a statutory four month hold period under applicable securities laws and the certificates evidencing the Common Shares and the Warrants will bear a legend to that effect. Closing of the Offering is expected to occur on or about June 22, 2022 or such other date as the Company may determine (the "Closing Date"), and is subject to certain conditions, including but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the Canadian Securities Exchange.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Reports Profitable Fiscal Q2 2022 with $11.1 Million in Revenue

Bloom Health Partners Reports Profitable Fiscal Q2 2022 with $11.1 Million in Revenue

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces unaudited Fiscal Q2 2022 revenues of CAD $11.1M for the period ended March 31st, 2022, bringing year-to-date revenues to $16.9M for the first half of Fiscal 2022.

Highlights in Fiscal Q2 2022:

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Invited to U.K. MedTech Trade Mission

Bloom Health Partners Invited to U.K. MedTech Trade Mission

British Columbia government selects Bloom, a leader in Workplace Health-Tech, to join event designed to open doors, facilitate partnerships, expand business

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a global platform for operational health, announced it has been asked by the British Columbia Ministry of Jobs, Economic Recovery & Innovation to join a government-supported virtual trade mission to the United Kingdom.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Extends Contract with State of Texas for K-12 Schools

Bloom Health Partners Extends Contract with State of Texas for K-12 Schools

Program for K-12 schools for lab-based testing along with supply and management of rapid tests is extended through the 2022-2023 school year in Texas.

 Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company") a global platform for operational health, announces that it has been awarded an extension of its state-wide contract for testing in Texas for K-12 schools to the end of the 2022-2023 school year. Bloom's program with schools in Texas, announced in January, includes both rapid and lab testing that covers the needs of schools as they plan for waves and variants associated with the pandemic. As previously announced, Bloom will conduct PCR testing in the Company's Dallas-based laboratory. Rapid tests will continue to be supplied to schools, with results data managed on Bloom's cloud data platform.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
dynaCERT Announces Auditor Resignation

dynaCERT Announces Auditor Resignation

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") announces the resignation of its auditors, BDO Canada LLP ("BDO"). BDO resigned on their own initiative, which resignation has been reviewed by dynaCERT 's audit committee. BDO has advised that its resignation is a business decision of such firm and has confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 Continuous Disclosure Obligations ) in connection with the change of auditor. dynaCERT is commencing the process to engage a replacement auditor for the 2022 fiscal year.

About dynaCERT Inc.
dyna CERT Inc. manufactures and distributes Carbon Emission Reduction Technology for use with internal combustion engines. As part of the growing global hydrogen economy, our patented technology creates hydrogen and oxygen on-demand through a unique electrolysis system and supplies these gases through the air intake to enhance combustion, resulting in lower carbon emissions and greater fuel efficiency. Our technology is designed for use with many types and sizes of diesel engines used in on-road vehicles, refrigerated trailers, off-road construction, power generation, mining and forestry equipment, marine vessels and railroad locomotives. Website: www.dynaCERT.com .

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results

Nano One Provides Quarterly Progress Update and Reports Q2 2022 Results

TSX:NANO) (OTC PINK:NNOMF) (Frankfurt:LBMB

nano one® Materials Corp. ("nano one" or the "Company") is a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries. nano one has filed its unaudited condensed interim consolidated financial statements (the "financial statements") and management's discussion & analysis for the second fiscal quarter ended June 30, 2022 and is pleased to provide the following highlights from Q2 2022.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Secures License for a Promising Novel Anti-Cancer Agent

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that it has secured an exclusive license from University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a biologic agent for the treatment of cancer.

The novel technology, originally developed by Suzanne Ostrand-Rosenberg, Ph.D., Emeritus Faculty at UMBC, and member of BriaCell's scientific advisory board, is titled "Soluble CD80 as a Therapeutic to Reverse Immune Suppression in Cancer Patients" and covered under USPN 8,956,619 B2 , USPN 9,650,429 B2 , and USPN 10,377,810 B2 . In animal models, sCD80 was well-tolerated and stopped tumor growth by potentially restoring natural anti-tumor immunity (see Lucas A Horn, et al . and Samuel T Haile et al. in collaboration with Dr. Ostrand-Rosenberg). Additionally, strong anti-tumor activity of sCD80 has been reported in multiple tumor types (see Lucas A Horn, et al .). Importantly, as demonstrated in the same studies, sCD80's unique actions may involve both awakening and boosting the immune system to recognize and destroy tumor cells.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

DGTL Holdings Inc. Reports Four New PaaS Contracts from Leading CPG Brands

Four Brands from Two Global CPG Conglomerates Leverage Patented Data and Analytics PaaS for Analysis of Digital Advertising Sponsorships During Top Broadcasted Sporting Event in North America

DGTL Holdings Inc. (TSXV: DGTL) ("DGTL" or the "Company") is pleased to announce that its wholly owned subsidiary Engagement Labs has secured four new PaaS (Platform-as-a-Service) contracts from two global consumer packaged goods (CPG) conglomerates.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Nano One Announces Results of Annual General Meeting

Nano One Announces Results of Annual General Meeting

nano one ® Materials Corp. (TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB) (the "Company"), a clean technology company with patented processes for the low-cost, low-environmental footprint production of high-performance cathode materials used in lithium-ion batteries, is pleased to announce the results of the annual general meeting of shareholders adjourned July 26, 2022, and reconvened today in Vancouver, British Columbia (the " Meeting

A total of 24,138,258 common shares were represented at the Meeting, representing 25.25% of the total issued and outstanding common shares of the Company.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Naturally Splendid Announces Proposed Consolidation and Special Meeting

Naturally Splendid Announces Proposed Consolidation and Special Meeting

Naturally Splendid Enterprises Ltd. ("Naturally Splendid" or "NSE" or the "Company") (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) announces that it intends to consolidate its issued and outstanding common shares at a ratio of up to fifteen (15) pre-consolidation shares to one (1) post-consolidation share (the "Consolidation"). The purpose of the Consolidation is to facilitate the Company's ability to attract future financings, generate greater investor interest, and improve trading liquidity

The Company currently has 330,624,458 common shares issued and outstanding. In the event the Company proceeds with the Consolidation, as opposed to a lesser ratio, the Company anticipates there would be 22,041,631 common shares issued and outstanding.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×